+248.8%
NBIS vs CVS
+35.9%
+212.8%
-48.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.5% | -0.5% | +8.0% | +7.6% |
| 7D | +8.2% | +4.0% | +4.3% | +7.1% |
| 30D | +3.4% | -2.4% | +5.8% | +4.0% |
| 3M | -12.8% | +2.7% | -15.5% | -13.2% |
| 6M | +131.5% | +21.9% | +109.7% | +120.4% |
| YTD | +170.5% | +24.7% | +145.7% | +146.6% |
| 1Y | +248.8% | +35.4% | +213.3% | +172.8% |
| All | +248.8% | +35.9% | +212.8% | +172.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling